SCHEMBL24299754

SCHEMBL24299754

CN1CCN(c2ccc3[nH]c(-c4ccc5nc(-c6ccc(OCCCCC(=O)NCCC(=O)O)cc6)[nH]c5c4)nc3c2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
MEN1 O00255 1/20 0.58
SLCO2B1 O94956 1/20 0.58
GLA P06280 1/20 0.58
MAPT P10636 1/20 0.58
RECQL P46063 1/20 0.58
BLM P54132 1/20 0.58
KMT2A Q03164 1/20 0.58
BCL2L1 Q07817 1/20 0.58
SLCO1B3 Q9NPD5 1/20 0.58
TDP1 Q9NUW8 1/20 0.58
SLCO1B1 Q9Y6L6 1/20 0.58
TOP1 P11387 3/20 0.55
TOP2A P11388 3/20 0.55
HDAC3 O15379 12/20 0.55
HDAC4 P56524 12/20 0.55
HDAC1 Q13547 12/20 0.55
HDAC7 Q8WUI4 12/20 0.55
HDAC2 Q92769 12/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24299746 0.93 ALDH1A1 (0.58) ALDH1A1SMN1; SMN2MEN1SLCO2B1GLA
SCHEMBL24299745 0.92 ALDH1A1 (0.66) ALDH1A1SMN1; SMN2MEN1SLCO2B1GLA
Bromide SCHEMBL25436047 0.92 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2MEN1SLCO2B1GLA
Bromide SCHEMBL30522158 0.92 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2MEN1SLCO2B1GLA
SCHEMBL24299753 0.91 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2MEN1SLCO2B1GLA
SCHEMBL25436540 0.90 ALDH1A1 (0.61) ALDH1A1SMN1; SMN2MEN1SLCO2B1GLA
Trifluoroacetic Acid SCHEMBL25297842 0.90 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2MEN1SLCO2B1GLA
SCHEMBL24299744 0.89 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2MEN1SLCO2B1GLA
SCHEMBL29412253 0.89 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2MEN1SLCO2B1GLA
SCHEMBL29412252 0.89 ALDH1A1 (0.55) ALDH1A1SMN1; SMN2MEN1SLCO2B1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220064710-A1 NUCLEIC ACID MODIFYING REAGENTS AND USES THEREOF PROMEGA CORPORATION 2022-03-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220064710-A1 NUCLEIC ACID MODIFYING REAGENTS AND USES THEREOF POLRMT, NSUN2, ADAR ALDH1A1 2687/4885SMN1; SMN2 1132/4885MEN1 3249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.